3/28
01:39 pm
dnli
Why Is Denali Therapeutics (DNLI) Up 2.8% Since Last Earnings Report? [Yahoo! Finance]
Low
Report
Why Is Denali Therapeutics (DNLI) Up 2.8% Since Last Earnings Report? [Yahoo! Finance]
3/26
08:29 am
dnli
Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson's Disease [Yahoo! Finance]
Low
Report
Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson's Disease [Yahoo! Finance]
3/19
08:30 am
dnli
Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
Medium
Report
Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
3/19
06:43 am
dnli
Further weakness as Denali Therapeutics (NASDAQ:DNLI) drops 7.4% this week, taking three-year losses to 67% [Yahoo! Finance]
Low
Report
Further weakness as Denali Therapeutics (NASDAQ:DNLI) drops 7.4% this week, taking three-year losses to 67% [Yahoo! Finance]
3/14
09:13 am
dnli
HiLabs Announces Closing of $39 Million Series B Financing to Advance its AI-powered Data Management Solutions for Healthcare Organizations [Yahoo! Finance]
Low
Report
HiLabs Announces Closing of $39 Million Series B Financing to Advance its AI-powered Data Management Solutions for Healthcare Organizations [Yahoo! Finance]
2/29
10:33 am
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $73.00 to $50.00. They now have a "buy" rating on the stock.
Low
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $73.00 to $50.00. They now have a "buy" rating on the stock.
2/28
01:10 pm
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) had its price target lowered by analysts at HC Wainwright from $105.00 to $95.00. They now have a "buy" rating on the stock.
Low
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) had its price target lowered by analysts at HC Wainwright from $105.00 to $95.00. They now have a "buy" rating on the stock.
2/28
09:33 am
dnli
Denali's (DNLI) Q4 Earnings Miss, Pipeline in Focus, Stock Up [Yahoo! Finance]
Neutral
Report
Denali's (DNLI) Q4 Earnings Miss, Pipeline in Focus, Stock Up [Yahoo! Finance]
2/28
09:31 am
dnli
Thinking about buying stock in QuickLogic, Ventyx Biosciences, Denali Therapeutics, Beyond Meat, or Archer Aviation?
Medium
Report
Thinking about buying stock in QuickLogic, Ventyx Biosciences, Denali Therapeutics, Beyond Meat, or Archer Aviation?
2/28
08:17 am
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $31.00 price target on the stock.
High
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $31.00 price target on the stock.
2/27
10:42 am
dnli
Seek Labs Welcomes Cindy Dunkle, Accomplished HR Leader with Extensive Life Sciences Experience, to Board of Directors [Yahoo! Finance]
High
Report
Seek Labs Welcomes Cindy Dunkle, Accomplished HR Leader with Extensive Life Sciences Experience, to Board of Directors [Yahoo! Finance]
2/27
08:43 am
dnli
Denali Therapeutics Inc (DNLI) Reports Full Year and Q4 2023 Financial Results [Yahoo! Finance]
High
Report
Denali Therapeutics Inc (DNLI) Reports Full Year and Q4 2023 Financial Results [Yahoo! Finance]
2/27
08:17 am
dnli
Denali Therapeutics Announces $500 million Private Placement Equity Financing [Yahoo! Finance]
High
Report
Denali Therapeutics Announces $500 million Private Placement Equity Financing [Yahoo! Finance]
2/27
08:17 am
dnli
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights [Yahoo! Finance]
High
Report
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights [Yahoo! Finance]
2/27
08:05 am
dnli
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
High
Report
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
2/27
08:00 am
dnli
Denali Therapeutics Announces $500 million Private Placement Equity Financing
High
Report
Denali Therapeutics Announces $500 million Private Placement Equity Financing
2/22
08:06 am
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $105.00 price target on the stock.
Low
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $105.00 price target on the stock.
2/13
05:05 am
dnli
10 'strong buy' stocks with price upsides from 84% to more than 243%, according to Wall Street's top analysts [Business Insider]
High
Report
10 'strong buy' stocks with price upsides from 84% to more than 243%, according to Wall Street's top analysts [Business Insider]
2/7
08:10 am
dnli
Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™ [Yahoo! Finance]
Low
Report
Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™ [Yahoo! Finance]
2/7
08:00 am
dnli
Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™
Low
Report
Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™
2/1
08:16 am
dnli
Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™ [Yahoo! Finance]
Low
Report
Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™ [Yahoo! Finance]
2/1
08:00 am
dnli
Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™
Low
Report
Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™
1/31
11:12 pm
dnli
Baillie Gifford Reduces Stake in Denali Therapeutics Inc [Yahoo! Finance]
Low
Report
Baillie Gifford Reduces Stake in Denali Therapeutics Inc [Yahoo! Finance]
1/9
08:44 am
dnli
DEAN BANKS APPOINTED CEO OF INDIGO AG AND CEO-PARTNER OF FLAGSHIP PIONEERING
Medium
Report
DEAN BANKS APPOINTED CEO OF INDIGO AG AND CEO-PARTNER OF FLAGSHIP PIONEERING
1/8
08:08 am
dnli
Denali Therapeutics Announces Key Anticipated 2024 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases [Yahoo! Finance]
Medium
Report
Denali Therapeutics Announces Key Anticipated 2024 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases [Yahoo! Finance]